Presentation is loading. Please wait.

Presentation is loading. Please wait.

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering  Terje R. Pedersen, MD, Lars Wilhelmsen,

Published byPetteri Niemi Modified over 6 years ago

Similar presentations

Presentation on theme: "Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering  Terje R. Pedersen, MD, Lars Wilhelmsen,"— Presentation transcript:

1 Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering  Terje R. Pedersen, MD, Lars Wilhelmsen, MD, Ole Færgeman, MD, Timo E. Strandberg, MD, Gudmundur Thorgeirsson, MD, Linda Troedsson, Johan Kristianson, Kåre Berg, MD, Thomas J. Cook, MS, Torben Haghfelt, MD, John Kjekshus, MD, Tatu Miettinen, MD, Anders G. Olsson, MD, Kalevi Pyörälä, MD, Hans Wedel, PhD  American Journal of Cardiology  Volume 86, Issue 3, Pages (August 2000) DOI: /S (00)

2 Figure 1 Profile of 4S. American Journal of Cardiology  , DOI: ( /S (00) )

3 Figure 2 Kaplan-Meier curves for all-cause mortality.
American Journal of Cardiology  , DOI: ( /S (00) )

4 Figure 3 Kaplan-Meier curves for cancer mortality.
American Journal of Cardiology  , DOI: ( /S (00) )

5 Figure 4 Kaplan-Meier curves for mortality in patients aged ≥65 years at baseline. American Journal of Cardiology  , DOI: ( /S (00) )

6 Figure 5 Kaplan-Meier curves for mortality in patients with LDL cholesterol <4.5 mmol/L at baseline. American Journal of Cardiology  , DOI: ( /S (00) )

Download ppt "Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering  Terje R. Pedersen, MD, Lars Wilhelmsen,"

Similar presentations

Cholesterol-Lowering Therapy in Women and Elderly Patients with Myocardial Infarction or Angina Pectoris Findings From the Scandinavian Simvastatin Survival.

Cholesterol-Lowering Therapy in Women and Elderly Patients with Myocardial Infarction or Angina Pectoris Findings From the Scandinavian Simvastatin Survival.
Effect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen, MD, John Kjekshus, MD, Kalevi.

Effect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen, MD, John Kjekshus, MD, Kalevi.
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304  Martin J. Edelman, MD, Lydia.

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB   Martin J. Edelman, MD, Lydia.
Relation of Heart Rate at Rest and Long-Term (>20 Years) Death Rate in Initially Healthy Middle-Aged Men  Xavier Jouven, MD, PhD, Jean Philippe Empana,

Relation of Heart Rate at Rest and Long-Term (>20 Years) Death Rate in Initially Healthy Middle-Aged Men  Xavier Jouven, MD, PhD, Jean Philippe Empana,
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Volume 105, Issue 3, Pages (March 1994)

Volume 105, Issue 3, Pages (March 1994)
Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Volume 128, Issue 2, Pages (August 2005)

Volume 128, Issue 2, Pages (August 2005)
Volume 127, Issue 6, Pages (June 2005)

Volume 127, Issue 6, Pages (June 2005)
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
Comparative Effectiveness of Adjunctive Bevacizumab for Advanced Lung Cancer: The Cancer Research Network Experience  Debra P. Ritzwoller, PhD, Nikki.

Comparative Effectiveness of Adjunctive Bevacizumab for Advanced Lung Cancer: The Cancer Research Network Experience  Debra P. Ritzwoller, PhD, Nikki.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Predicting Survival in Oldest Old People

Predicting Survival in Oldest Old People
Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer  Lee.

Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer  Lee.
Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.

Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data  Chris R. Kelsey, MD, Kristin.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors  Andrea L. Cheville, MD, MSCE,

The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors  Andrea L. Cheville, MD, MSCE,
Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E

Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E
Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2  Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.

Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2  Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.

Similar presentations

Ads by Google